Bremer Bank National Association Abb Vie Inc. Transaction History

Bremer Bank National Association

$526 Million
Q3 2024

A detailed history of Bremer Bank National Association transactions in Abb Vie Inc. stock. As of the latest transaction made, Bremer Bank National Association holds 3,287 shares of ABBV stock, worth $577,131. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,287

Previous 3,764 12.67%

Holding current value

$577,131

Previous $645,000 0.62%

% of portfolio

0.12%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$163.84 - $199.33 $78,151 - $95,080	-477 Reduced 12.67%	3,287 $649,000
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $23,992 - $28,017	-155 Reduced 3.96%	3,764 $645,000
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $955,084 - $1.09 Million	-5,976 Reduced 60.39%	3,919 $713,000
Q4 2023 Jan 11, 2024	SELL	$137.6 - $154.97 $8,806 - $9,918	-64 Reduced 0.64%	9,895 $1.53 Million
Q3 2023 Oct 20, 2023	SELL	$133.59 - $154.65 $40,611 - $47,013	-304 Reduced 2.96%	9,959 $1.48 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $35,247 - $43,863	-266 Reduced 2.53%	10,263 $1.38 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $88,790 - $102,255	-614 Reduced 5.51%	10,529 $1.68 Million
Q4 2022 Jan 12, 2023	BUY	$138.31 - $165.87 $815,475 - $977,969	5,896 Added 112.37%	11,143 $1.8 Million
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $42,141 - $48,334	-314 Reduced 5.65%	5,247 $705,000
Q2 2022 Jul 08, 2022	SELL	$137.62 - $174.96 $35,781 - $45,489	-260 Reduced 4.47%	5,561 $852,000
Q1 2022 Apr 07, 2022	SELL	$131.98 - $163.75 $108,487 - $134,602	-822 Reduced 12.37%	5,821 $944,000
Q4 2021 Jan 10, 2022	BUY	$107.43 - $135.93 $1,396 - $1,767	13 Added 0.2%	6,643 $899,000
Q3 2021 Oct 05, 2021	BUY	$106.4 - $120.78 $9,150 - $10,387	86 Added 1.31%	6,630 $715,000
Q2 2021 Jul 13, 2021	SELL	$105.21 - $117.21 $25,460 - $28,364	-242 Reduced 3.57%	6,544 $737,000
Q1 2021 Apr 07, 2021	SELL	$102.3 - $112.62 $47,671 - $52,480	-466 Reduced 6.43%	6,786 $735,000
Q4 2020 Jan 12, 2021	SELL	$80.49 - $108.67 $22,939 - $30,970	-285 Reduced 3.78%	7,252 $777,000
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $245,444 - $288,071	-2,857 Reduced 27.49%	7,537 $660,000
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $12,913 - $17,279	-176 Reduced 1.67%	10,394 $1.02 Million
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $5,095 - $7,725	-79 Reduced 0.74%	10,570 $805,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $225,983 - $282,753	3,133 Added 41.68%	10,649 $943,000
Q3 2019 Oct 03, 2019	SELL	$62.98 - $75.72 $102,909 - $123,726	-1,634 Reduced 17.86%	7,516 $569,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $171,936 - $219,775	-2,617 Reduced 22.24%	9,150 $666,000
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $907,706 - $1.07 Million	11,767 New	11,767 $934,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.

Account

Bremer Bank National Association Abb Vie Inc. Transaction History